Written answers
Wednesday, 22 January 2025
Department of Health
Medicinal Products
Duncan Smith (Dublin Fingal East, Labour)
Link to this: Individually | In context | Oireachtas source
1367. To ask the Minister for Health if his attention has been drawn to a drug shortage (details supplied); the steps that will be taken to address this shortage; and if he will make a statement on the matter. [46537/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
In Ireland, we have a multi-stakeholder Medicines Shortages Framework in place, operated by our medicines regulator, the Health Products Regulatory Authority (HPRA) on behalf of the Department of Health. The framework aims to help prevent potential shortages from occurring and to reduce the impact of shortages on patients by coordinating the management of potential or actual shortages as they arise. Stakeholders in this framework include the HPRA, the Department, the HSE, healthcare professionals, manufacturers, wholesalers, patient representative groups and marketing authorisation holders.
The HPRA have not been notified of an ongoing shortage of Tyvense (lisdexamphetamine). A previous shortage of Tyvense 30mg Hard Capsules was resolved on 13th November 2024.
The HPRA maintains a list of current and resolved shortages on its . The webpage is updated daily as the HPRA receives new information.
Paul McAuliffe (Dublin North-West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1368. To ask the Minister for Health the HSEs position on paxlovid and to provide an explanation. [46539/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
Paul Murphy (Dublin South West, Solidarity)
Link to this: Individually | In context | Oireachtas source
1369. To ask the Minister for Health if he will ensure that glp1-type medications to assist with weight loss are covered under the DPS scheme, in particular where they are prescribed to patients with severe co-morbidities such a heart disease; and if he will make a statement on the matter. [46546/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments